CVR number 37815551
Industry 86.9040 Other human health activities

Kiropraktor MJ ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  8.9% 13.7% 13.5% 8.4% 6.3%  
Credit score (0-100)  29 16 15 28 36  
Credit rating  BB BB BB BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  1,359 2,006 2,264 2,153 2,201  
EBITDA  358 71.7 239 255 201  
EBIT  179 -96.4 130 187 110  
Pre-tax profit (PTP)  88.7 -182.4 45.2 117.9 21.9  
Net earnings  68.3 -143.3 50.5 92.0 9.2  
Pre-tax profit without non-rec. items  88.7 -182 45.2 118 21.9  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  173 117 56.8 137 123  
Shareholders equity total  97.6 -162 -111 58.7 67.9  
Interest-bearing liabilities  0.0 8.1 0.0 0.0 0.0  
Balance sheet total (assets)  1,190 1,121 1,321 1,310 1,045  
Net Debt  -143 8.1 -249 -257 -137  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,359 2,006 2,264 2,153 2,201  
Gross profit growth  58.7% 47.6% 12.9% -4.9% 2.2%  
Employees  4 4 4 3 3  
Employee growth %  100.0% 0.0% 0.0% -25.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,190 1,121 1,321 1,310 1,045  
Balance sheet change%  8.9% -5.8% 17.8% -0.8% -20.3%  
Added value  357.5 71.7 238.9 295.8 201.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -311 -321 -218 -115 -61  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 -1.0 1.0 2.0 3.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  13.2% -4.8% 5.7% 8.7% 5.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  15.7% -7.8% 9.6% 13.6% 9.4%  
ROI %  259.4% -164.8% 3,204.3% 507.6% 131.5%  
ROE %  107.7% -23.5% 4.1% 13.3% 14.6%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  8.2% -12.6% -7.8% 4.5% 6.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -40.0% 11.3% -104.3% -100.6% -68.2%  
Gearing %  0.0% -5.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 2,122.6% 2,088.8% 0.0% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.3 0.3 0.5 0.5 0.5  
Current Ratio  0.3 0.3 0.5 0.5 0.5  
Cash and cash equivalent  142.9 0.0 249.2 256.5 137.1  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -790.6 -920.3 -748.3 -595.2 -509.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  89 18 60 99 67  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  89 18 60 85 67  
EBIT / employee  45 -24 32 62 37  
Net earnings / employee  17 -36 13 31 3